@FierceMedDev: Mindray, a giant Chinese medical device company, has just expanded an already impressive share repurchase program. More | Follow @FierceMedDev
@MarkHFierce: Google Glass is showing some promise as a medical diagnostic tool. Cool stuff, with pictures. Story | Follow @MarkHFierce
@MichaelGFierce: New manufacturing technique offers tailored delivery nanoparticles made of iron, silver and silicon. More from FierceDrugDelivery | Follow @MichaelGFierce
@EmilyWFierce: Researchers created custom-fitting heart sacs that could help with treatment. Article | Follow @EmilyWFierce
> Corium International has filed plans for a proposed $50 million IPO. The Califorina company is developing drugs that rely on special transdermal and transmucosal delivery technology. S-1
> Hospira ($HSP) named David Endicott as president of its Hopsira Medical Devices division, a newly-created position charged with developing "a fully integrated device organization." Item
> Blockade Medical gained 510(k) clearance for two new improvements to catheter devices designed to treat cerebral aneurysms. Item
> Bruin Biometrics raised $10 million to advance work on its wound, joint and implant scanning devices. Story
> Heart implants can be theoretically produced by 3-D printer now to fit specific patients. Story
> J. Craig Venter has announced the "biggest gene sequence project" ever. News
Biotech News
@FierceBiotech: Theravance bets it can innovate without GlaxoSmithKline as spinoff nears. Story | Follow @FierceBiotech
@JohnCFierce: The coming Zohydro addiction issue is a natural mainstream media piece--sets the FDA up for a big black eye with more to come. Story via CBS | Follow @JohnCFierce
@DamianFierce: On his farewell tour, Roche Chairman Franz Humer says Roche is poised for some dealmaking. News | Follow @DamianFierce
@EmilyMFierce: BioCryst compound prevents Marburg virus in monkeys. Article | Follow @EmilyMFierce
> Oxygen Bio shares soar after FDA lifts hold on brain injury drug. More
> Biotech parties on with billions more raised for R&D work. Story
Pharma News
@FiercePharma: As in...right now. The top 10 pharma companies by 2013 revenue report is live on the FP site. Report | Follow @FiercePharma
@TracyStaton: This year's version of FiercePharma's most popular special report: The top 10 pharma companies by 2013 revenue. More | Follow @TracyStaton
@EricPFierce: WSJ says Pfizer angling for OTC Lipitor. That will get generic drugmakers' notice. Story | Follow @EricPFierce
@CarlyHFierce: New report, now live: The top 10 pharma companies by 2013 revenue. Report | Follow @CarlyHFierce
> Takeda fesses up to improperly marketing its blood-pressure blockbuster, Blopress. Article
> Sanofi slapped with €28M bribery fine for former German employees' scheme. Piece
> Lilly, Pfizer and Merck slash doctor payments, but J&J and Forest shell out more. More
Biotech Research News
> HIV immune discovery could lay the groundwork for a vaccine. Story
> Experimental supplement extends lifespan, stops metabolic disease in mice. Article
> BioCryst compound prevents Marburg virus in monkeys. News
> New anti-inflammatory molecule could provide a model for new drug design. Article
> Brain cell communication plays role in regulating Alzheimer's protein. Story
> NIH makes new database on age-related diseases available to researchers. Brief
Pharma Manufacturing News
> Regeneron preparing for a plant expansion and a fill-finish facility in Ireland. Story
> Jubilant says the FDA has cleared its Canada plant. News
> Fresenius to build new plant in Australia. Story
> Lilly invests in its Brazilian packaging plant. Article
> Drug purchasing group wants drugmakers to work with GPOs on shortages. Story
> Pharma packaging market is forecast to hit $90 billion in 2017. Brief